Lenacapavir sodium, CAS [[2283356-12-5]] Preis auf Anfrage

Produktübersicht

• Artikelname: Lenacapavir sodium, CAS [[2283356-12-5]] Preis auf Anfrage
• Artikelnummer: TGM-T202890
• Hersteller Artikelnummer: T202890
• Alternativnummer: TGM-T202890-10MG,TGM-T202890-50MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: GS-HIV Na , BDT58WJ9WE , GS-HIV Sodium

Produktbeschreibung

Lenacapavir, also known as GS-6207, is an HIV-1 capsid inhibitor. It demonstrates an average EC50 of 50 pM (ranging from 20-160 pM) against 23 clinical isolates of HIV-1 from diverse subtypes, with tests performed in peripheral blood mononuclear cells (PBMCs). In vitro, Lenacapavir exhibits picomolar potency and shows no cross-resistance with existing antiretroviral compounds. Furthermore, Lenacapavir displays significant antiviral activity in individuals with HIV-1, regardless of prior treatment history, with no pre-existing resistance detected.

Produkteigenschaften

• Molekulargewicht: 990.26
• CAS Nummer: [2283356-12-5]
• Formel: C39H31ClF10N7NaO5S2
• Target-Kategorie: HIV Protease

Bilder

T202890